Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthamber Regulatory News (NAR)

Share Price Information for Northamber (NAR)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
23.00
Ask:
27.00
Spread: 4.00 (17.391%)
Market Cap: £6.78m
NAR Live PriceLast checked at - London Stock Exchange

Intraday Northamber Share Chart

Interim Management Statement

17 Nov 2011 15:54

RNS Number : 3200S
Northamber PLC
17 November 2011
 



17 November 2011

 

Northamber plc

Interim Management Statement

 

The results of the strategic refocus of the business model in my last update to shareholders and the repositioning of our vendor offerings, are starting to bear fruit. Sales in Q1 of the current financial year improved by some 9% over the Q4 sales to 30 June 2011.

 

However, as widely published, all volume product sectors continue to suffer significantly from reducing demand and resultant over-supply. Context's market analysis on European I.T. distribution stated that Q3 demand had decreased by 18% over 2010.

 

On our own volume product portfolio, we were not immune to the lower levels of demand. Consequential oversupply and commensurate vendor destocking actions adversely affected our overall margins. Despite having taken avoiding actions and our areas of success, overall gross profit margins of 6.5% for our July to September Q1 compared with 7.0% for last year as a whole.

 

The combination of de-positioning the empty-revenue portion of our volume portfolio offerings and the wider economic downturn resulted in a 29% reduction in total sales in Q1 to 30 September 2011 of this financial year compared with Q1 last year.

 

The effects of the significant falls in selling prices per unit of the oversupplied volume products has resulted in our costs of sale being a greater daily management challenge.

 

As always we operate very strict cost controls on every aspect of the business. Whilst continuing to work to bring the cost ratios back into line with our needs and expectations, since the start of 2011 the underlying uncertainties have presented additional challenges to the business.

 

Some pre-emptive significant cost savings have already been implemented and will be recognised in the second half of the current financial year, and beyond. However, the unabated pressures of the on-going challenges are keeping this subject at the forefront of our attentions.

 

The extent of the volume product sector downturn can best be assessed at the operating level where the loss in Q1 to 30 September 2011 of 1.6% of sales, compared with a profit of 0.4% of sales in Q1 last year and a near break-even level for last year as a whole.

 

After buying another 150,000 ordinary shares for treasury at a cost of £86,155, we continue to maintain a very high level cash balances, with zero borrowings. The cash balance at the end of Q1 this year was £9.08 million compared with £10.7 million at 30 June. Whilst the rates of interest remain at a consistent low level, the income from these balances is minimal.

 

Net Assets per share at 30 September 2011 were 85.2 pence per share, compared with 86.5 pence per share at the end of June 2011.

 

For the present, there is no clear indication of any early improvement in the industry outlook. Hopefully when the overstocking situation is resolved there may be a return to a more rational balance of product and pricing. In the meantime we can only continue to operate as efficiently and effectively as we can.

 

For further information please contact:

 

Northamber plc 020 8296 7000

David Phillips

 

FoxDavies Capital 020 3463 5000

Barry Saint

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDKODPPBDDNDD
Date   Source Headline
11th Nov 20107:59 amRNSInterim Management Statement
28th Sep 201012:17 pmRNSTransaction in Own Shares
7th Sep 20107:00 amRNSFinal Results
12th May 20108:27 amRNSTransaction in Own Shares
5th May 20107:00 amRNSInterim Management Statement
31st Mar 20104:57 pmRNSTransaction in Own Shares
9th Mar 20105:00 pmRNSTransaction in Own Shares
26th Feb 20104:59 pmRNSTransaction in Own Shares
19th Feb 20107:00 amRNSTransaction in Own Shares
18th Feb 20107:00 amRNSHalf Yearly Report
22nd Dec 200910:02 amRNSTotal Voting Rights
10th Dec 20092:55 pmRNSTransaction in Own Shares
17th Nov 20093:49 pmRNSInterim Management Statement
24th Sep 20097:00 amRNSFinal Results
5th Jun 20097:00 amRNSChange of Registered Office
30th Apr 20097:00 amRNSInterim Management Statement
19th Feb 20097:00 amRNSInterim Results
2nd Dec 20084:27 pmRNSDirector/PDMR Shareholding
21st Nov 20084:03 pmRNSTransaction in Own Shares
14th Nov 20083:17 pmRNSInterim Management Statement
30th Oct 20087:00 amRNSNorthamber Distribution Contract
24th Sep 20087:00 amRNSFinal Results
16th May 20089:12 amRNSInterim Management Statement
3rd Apr 200812:42 pmRNSResult of EGM
11th Mar 20083:50 pmRNSCapital Reorganisation
29th Feb 20081:31 pmRNSInterim Results
27th Nov 20071:09 pmRNSTransaction in Own Shares
22nd Nov 20076:09 pmRNSTransaction in Own Shares
19th Nov 20073:10 pmRNSTransaction in Own Shares
16th Nov 20071:13 pmRNSInterim Management Statement
5th Oct 20077:00 amRNSFinal Results
15th Aug 20071:14 pmRNSHolding(s) in Company
22nd Mar 20073:03 pmRNSHolding(s) in Company
22nd Mar 20073:00 pmRNSHolding(s) in Company
21st Mar 200712:44 pmRNSHolding(s) in Company
28th Feb 20077:02 amRNSInterim Results
19th Dec 200610:27 amRNSTotal Voting Rights
5th Oct 20067:01 amRNSFinal Results
26th May 20063:16 pmRNSTransaction in Own Shares
15th Mar 20067:00 amRNSInterim Results
29th Nov 20051:04 pmRNSDirector/PDMR Shareholding
25th Nov 20057:00 amRNSTrading Statement
12th Oct 20057:00 amRNSTransaction in Own Shares
21st Sep 20057:00 amRNSFinal Results
10th Jun 20055:38 pmRNSTransaction in Own Shares
10th Jun 20059:47 amRNSTransaction in Own Shares
9th Jun 20053:31 pmRNSTransaction in Own Shares
17th May 20055:40 pmRNSTransaction in Own Shares
16th May 200510:55 amRNSTrading Statement
12th May 20054:10 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.